Canadian Overseas Petroleum Ltd Announces Liberia Update

CALGARY, AB -- (Marketwired) -- 06/02/15 -- Canadian Overseas Petroleum (TSX VENTURE: XOP) (LSE: COPL)

TSX-V: XOP; LSE: COPL

Canadian Overseas Petroleum

LIBERIA UPDATE

Calgary, Canada,

June 2, 2015 - Canadian Overseas Petroleum Limited ("COPL" or the "Company") (TSX-V: XOP; LSE: COPL); along with its partner, ExxonMobil, remain committed to completing their work program and obligations under the LB-13 amended and restated Production Sharing Contract ("PSC") dated March 31, 2013. NOCAL and ExxonMobil, the operator, continue to meet regularly to discuss operations, Community and Social Responsibility activities and the fulfillment of the LB-13 work program, which has been affected by the Ebola Crisis. The government of Liberia continues to provide its assurances that it will act under the terms of the PSC to provide the Company and ExxonMobil sufficient time to complete their work program, extending the current exploration period if necessary. ExxonMobil continued to support relief organizations in Liberia throughout the crisis, demonstrating their commitment to the region. Now that Liberia has been declared Ebola-free by the WHO, the operator is planning next steps for operations.

For Further Information Please Contact:

Arthur Millholland, President and CEO Phone: + 1 403 262 5441

Investor and Public Relations

Bell Pottinger Henry Lerwill +44 (0) 203 772 2500 North America Toll Free: +1 866 834 8330

CHF Investor Relations Robin Cook +1 (416) 868 1079 ext. 228

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This information is provided by RNS The company news service from the London Stock Exchange

Contact:
RNS
Customer Services
0044-207797-4400
[email protected]
http://www.rns.com

Source: Canadian Overseas Petroleum Ltd

You May Also Be Interested In

• Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison
• ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIV
• LG Energy Solution Makes Progress Amid Market Uncertainties, Aims to Strengthen Fundamental Competitiveness This Year